VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised
Vertex(VRTX) ZACKS·2024-11-06 01:26
Vertex Pharmaceuticals Incorporated (VRTX) reported adjusted earnings of $4.38 per share for the third quarter of 2024, surpassing the Zacks Consensus Estimate of $4.13. In the year-ago quarter, the company had recorded adjusted earnings of $4.08 per share. Earnings grew year over year owing to increased product revenues.The company reported total revenues of $2.77 billion for the third quarter, comprising cystic fibrosis (CF) product revenues. The figure beat the Zacks Consensus Estimate of $2.67 billion. ...